|
ZNF136 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.08795219897229E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58710000697226E-09 |
| Normal-vs-Stage2 |
3.68279999996002E-06 |
| Normal-vs-Stage3 |
1.08010045352103E-10 |
| Normal-vs-Stage4 |
2.59419996595511E-09 |
| Stage1-vs-Stage2 |
6.323800E-01 |
| Stage1-vs-Stage3 |
3.823900E-02 |
| Stage1-vs-Stage4 |
2.154400E-02 |
| Stage2-vs-Stage3 |
3.304200E-01 |
| Stage2-vs-Stage4 |
1.445800E-01 |
| Stage3-vs-Stage4 |
4.956400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.33819999525997E-08 |
| Normal-vs-AfricanAmerican |
1.218110E-02 |
| Normal-vs-Asian |
3.7081999999522E-06 |
| Caucasian-vs-AfricanAmerican |
2.611400E-01 |
| Caucasian-vs-Asian |
4.325400E-01 |
| AfricanAmerican-vs-Asian |
5.128200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.99869999731817E-08 |
| Normal-vs-Female |
2.46389575409012E-11 |
| Male-vs-Female |
8.939800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.06570000286177E-08 |
| Normal-vs-Age(41-60Yrs) |
1.92119986586192E-10 |
| Normal-vs-Age(61-80Yrs) |
2.91790036577311E-10 |
| Normal-vs-Age(81-100Yrs) |
2.280500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.571350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.425800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.459400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.417400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.729000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.073800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.455290E-03 |
| Classical-VS-Follicular |
1.813360E-01 |
| Classical-VS-Other |
6.486800E-01 |
| Classical-VS-Normal |
1.09810000004096E-06 |
| Tall-VS-Follicular |
6.731800E-02 |
| Tall-VS-Other |
4.927200E-01 |
| Tall-VS-Normal |
1.64169999816721E-09 |
| Follicular-VS-Other |
9.944000E-01 |
| Follicular-VS-Normal |
4.30619999658433E-08 |
| Other-VS-Normal |
2.259800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.03549999078234E-09 |
| Normal-vs-N1 |
1.33669999513586E-08 |
| N0-vs-N1 |
9.785700E-02 |
|
|
